Procter & Gamble Health Ltd

Other Announcement

Procter & Gamble Health Other Announcement

Procter & Gamble Health informed shareholders about an extended SEBI-mandated special window for re-lodging rejected physical share transfer requests until February 4, 2027.

Management Change

Procter & Gamble Health Management Change

Procter & Gamble Health shareholders approved the re-appointment of Mr. S. Madhavan as an Independent Director for a five-year term starting November 15, 2026.

Execution

5 years

Annual General Meeting

Procter & Gamble Health Annual General Meeting

Procter & Gamble Health held its 59th Annual General Meeting on September 3, 2026, where shareholders discussed financial results and directorial appointments.

Financial Results

Procter & Gamble Health Q1 FY27 Results: Net Profit ₹96.2 Cr, Up 45.3% YoY

Procter & Gamble Health Ltd reported revenue from operations of ₹363.7 Cr (+7.4% YoY) and net profit of ₹96.2 Cr (+45.3% YoY) for Q1 FY27.

Key figure

Net profit ₹96.2 Cr · +45.3% YoY

Financial ResultsAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Procter & Gamble Health Q4 FY26 Results: Net Profit ₹94.6 Cr, Up 54.6% YoY

Procter & Gamble Health Ltd reported revenue from operations of ₹370.4 Cr (+19.1% YoY) and net profit of ₹94.6 Cr (+54.6% YoY) for Q4 FY26.

Key figure

Net profit ₹94.6 Cr · +54.6% YoY